Your browser doesn't support javascript.
loading
Association of a Schizophrenia-Risk Nonsynonymous Variant With Putamen Volume in Adolescents: A Voxelwise and Genome-Wide Association Study.
Luo, Qiang; Chen, Qiang; Wang, Wenjia; Desrivières, Sylvane; Quinlan, Erin Burke; Jia, Tianye; Macare, Christine; Robert, Gabriel H; Cui, Jing; Guedj, Mickaël; Palaniyappan, Lena; Kherif, Ferath; Banaschewski, Tobias; Bokde, Arun L W; Büchel, Christian; Flor, Herta; Frouin, Vincent; Garavan, Hugh; Gowland, Penny; Heinz, Andreas; Ittermann, Bernd; Martinot, Jean-Luc; Artiges, Eric; Paillère-Martinot, Marie-Laure; Nees, Frauke; Orfanos, Dimitri Papadopoulos; Poustka, Luise; Fröhner, Juliane H; Smolka, Michael N; Walter, Henrik; Whelan, Robert; Callicott, Joseph H; Mattay, Venkata S; Pausova, Zdenka; Dartigues, Jean-François; Tzourio, Christophe; Crivello, Fabrice; Berman, Karen F; Li, Fei; Paus, Tomás; Weinberger, Daniel R; Murray, Robin M; Schumann, Gunter; Feng, Jianfeng.
Afiliação
  • Luo Q; Institute of Science and Technology for Brain-Inspired Intelligence, Fudan University, Shanghai, China.
  • Chen Q; Ministry of Education-Key Laboratory of Computational Neuroscience and Brain-Inspired Intelligence, Fudan University, Shanghai, China.
  • Wang W; School of Life Sciences and State Key Laboratory of Genetic Engineering, Fudan University, Shanghai, China.
  • Desrivières S; Centre for Population Neuroscience and Precision Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, Social Genetic and Developmental Psychiatry Centre, London, England.
  • Quinlan EB; Lieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, Maryland.
  • Jia T; Pharnext, Issy-les-Moulineaux, Ile de France, France.
  • Macare C; Institut National de la Santé et de la Recherche Médicale Unit 897, University of Bordeaux, Bordeaux, Aquitaine, France.
  • Robert GH; Centre for Population Neuroscience and Precision Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, Social Genetic and Developmental Psychiatry Centre, London, England.
  • Cui J; Centre for Population Neuroscience and Precision Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, Social Genetic and Developmental Psychiatry Centre, London, England.
  • Guedj M; Institute of Science and Technology for Brain-Inspired Intelligence, Fudan University, Shanghai, China.
  • Palaniyappan L; Ministry of Education-Key Laboratory of Computational Neuroscience and Brain-Inspired Intelligence, Fudan University, Shanghai, China.
  • Kherif F; Centre for Population Neuroscience and Precision Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, Social Genetic and Developmental Psychiatry Centre, London, England.
  • Banaschewski T; Centre for Population Neuroscience and Precision Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, Social Genetic and Developmental Psychiatry Centre, London, England.
  • Bokde ALW; EA 4712 "Behavior and Basal Ganglia," Rennes University 1, Rennes, France.
  • Büchel C; Laboratory for Research in Neuroimaging, Department of Clinical Neurosciences, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland.
  • Flor H; Pharnext, Issy-les-Moulineaux, Ile de France, France.
  • Frouin V; Departments of Psychiatry and Medical Biophysics, Robarts Research Institute, University of Western Ontario, London, Ontario, Canada.
  • Garavan H; Laboratory for Research in Neuroimaging, Department of Clinical Neurosciences, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland.
  • Gowland P; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Square J5, Mannheim, Germany.
  • Heinz A; Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland.
  • Ittermann B; University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
  • Martinot JL; Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Artiges E; Department of Psychology, School of Social Sciences, University of Mannheim, Mannheim, Germany.
  • Paillère-Martinot ML; NeuroSpin, Commissariat à L'énergie Atomique, Université Paris-Saclay, Gif-sur-Yvette, France.
  • Nees F; Departments of Psychiatry and Psychology, University of Vermont, Burlington.
  • Orfanos DP; Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, England.
  • Poustka L; Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité, Universitätsmedizin Berlin, Germany.
  • Fröhner JH; Physikalisch-Technische Bundesanstalt Braunschweig and Berlin, Berlin, Germany.
  • Smolka MN; Institut National de la Santé et de la Recherche Médicale Unit 1000, Neuroimaging and Psychiatry, University Paris Sud-Paris Saclay, University Paris Descartes, Paris, France.
  • Walter H; Service Hospitalier Frédéric Joliot, Orsay, France.
  • Whelan R; Maison de Solenn, Paris, France.
  • Callicott JH; Institut National de la Santé et de la Recherche Médicale Unit 1000, Neuroimaging and Psychiatry, University Paris Sud-Paris Saclay, University Paris Descartes, Paris, France.
  • Mattay VS; Service Hospitalier Frédéric Joliot, Orsay, France.
  • Pausova Z; GH Nord Essonne Psychiatry Department, Orsay, France.
  • Dartigues JF; Institut National de la Santé et de la Recherche Médicale Unit 1000, Neuroimaging and Psychiatry, University Paris Sud-Paris Saclay, University Paris Descartes, Paris, France.
  • Tzourio C; Assistance Publique-Hôpitaux de Paris, Department of Child and Adolescent Psychiatry, Pitié-Salpêtrière Hospital, Paris, France.
  • Crivello F; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Square J5, Mannheim, Germany.
  • Berman KF; Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Li F; NeuroSpin, Commissariat à L'énergie Atomique, Université Paris-Saclay, Gif-sur-Yvette, France.
  • Paus T; Department of Child and Adolescent Psychiatry and Psychotherapy, University Medical Centre Göttingen, Göttingen, Germany.
  • Weinberger DR; Clinic for Child and Adolescent Psychiatry, Medical University of Vienna, Währinger Gürtel, Vienna, Austria.
  • Murray RM; Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany.
  • Schumann G; Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany.
  • Feng J; Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité, Universitätsmedizin Berlin, Germany.
JAMA Psychiatry ; 76(4): 435-445, 2019 04 01.
Article em En | MEDLINE | ID: mdl-30649180
ABSTRACT
Importance Deviation from normal adolescent brain development precedes manifestations of many major psychiatric symptoms. Such altered developmental trajectories in adolescents may be linked to genetic risk for psychopathology.

Objective:

To identify genetic variants associated with adolescent brain structure and explore psychopathologic relevance of such associations. Design, Setting, and

Participants:

Voxelwise genome-wide association study in a cohort of healthy adolescents aged 14 years and validation of the findings using 4 independent samples across the life span with allele-specific expression analysis of top hits. Group comparison of the identified gene-brain association among patients with schizophrenia, unaffected siblings, and healthy control individuals. This was a population-based, multicenter study combined with a clinical sample that included participants from the IMAGEN cohort, Saguenay Youth Study, Three-City Study, and Lieber Institute for Brain Development sample cohorts and UK biobank who were assessed for both brain imaging and genetic sequencing. Clinical samples included patients with schizophrenia and unaffected siblings of patients from the Lieber Institute for Brain Development study. Data were analyzed between October 2015 and April 2018. Main Outcomes and

Measures:

Gray matter volume was assessed by neuroimaging and genetic variants were genotyped by Illumina BeadChip.

Results:

The discovery sample included 1721 adolescents (873 girls [50.7%]), with a mean (SD) age of 14.44 (0.41) years. The replication samples consisted of 8690 healthy adults (4497 women [51.8%]) from 4 independent studies across the life span. A nonsynonymous genetic variant (minor T allele of rs13107325 in SLC39A8, a gene implicated in schizophrenia) was associated with greater gray matter volume of the putamen (variance explained of 4.21% in the left hemisphere; 8.66; 95% CI, 6.59-10.81; P = 5.35 × 10-18; and 4.44% in the right hemisphere; t = 8.90; 95% CI, 6.75-11.19; P = 6.80 × 10-19) and also with a lower gene expression of SLC39A8 specifically in the putamen (t127 = -3.87; P = 1.70 × 10-4). The identified association was validated in samples across the life span but was significantly weakened in both patients with schizophrenia (z = -3.05; P = .002; n = 157) and unaffected siblings (z = -2.08; P = .04; n = 149). Conclusions and Relevance Our results show that a missense mutation in gene SLC39A8 is associated with larger gray matter volume in the putamen and that this association is significantly weakened in schizophrenia. These results may suggest a role for aberrant ion transport in the etiology of psychosis and provide a target for preemptive developmental interventions aimed at restoring the functional effect of this mutation.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Putamen / Esquizofrenia / Proteínas de Transporte de Cátions / Estudo de Associação Genômica Ampla / Substância Cinzenta Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Male Idioma: En Revista: JAMA Psychiatry Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Putamen / Esquizofrenia / Proteínas de Transporte de Cátions / Estudo de Associação Genômica Ampla / Substância Cinzenta Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Male Idioma: En Revista: JAMA Psychiatry Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China